Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Active, not recruiting · NCT05736523 · Registry updated 2025-03-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Not stated | 2025-03-07 | NCT05736523 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Intermountain Health Care, Inc. | 28 |
| Natera, Inc. | 45 |
| University of Utah | 319 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huntsman Cancer Institute | Salt Lake City | United States | 107 |
| Intermountain Medical Center | Murray | United States | 142 |